Duodenoscope Reprocessing Failures: Breach, Look-Back, and Surveillance Cultures
A 350-bed hospital's endoscopy suite performs about 40 ERCPs per month with two duodenoscopes. Both are manually cleaned with a manufacturer-specified elevator brush and then processed in a single automated endoscope reprocessor (AER) using ortho-phthalaldehyde (OPA). In March, a patient develops Klebsiella pneumoniae bacteremia five days after ERCP, and review identifies two more patients with Klebsiella pneumoniae cultures within six weeks. The infection preventionist pulls reprocessing logs: on four occasions manual cleaning began more than six hours after the procedure because scopes sat in transport containers after staff went home; on two of those occasions the elevator brush was not used because it was out of stock. Alcohol flush and forced-air drying were functioning, but one scope was stored in the cabinet with the elevator in the closed position. The facility does not perform surveillance cultures on scopes. The endoscopy manager asks whether a patient look-back is warranted and whether the scopes can stay in service.
1. Is this a reprocessing breach? Identify the specific failures, and state whether a look-back and patient notification are indicated.
Read the worked answer
Yes - multiple breaches, each independently disqualifying.
- Delayed manual cleaning. Organic material and biofilm dry in channels and the elevator mechanism; most manufacturer instructions for use specify cleaning within a defined interval after the procedure (commonly on the order of an hour). Six hours is outside any plausible instruction.
- Elevator brush omitted. The elevator is the hardest site to clean and the exact location implicated in duodenoscope transmission. Skipping the brush leaves a critical site uncleaned regardless of what the AER does downstream - high-level disinfection cannot compensate for retained bioburden.
- Storage with the elevator closed. Instructions for use generally require the elevator to be open during storage so air can circulate; closing it traps moisture and creates a growth niche.
- A brush shortage caused the breach. This is a supply and staffing failure, not an individual's carelessness - treat it as a system problem.
Look-back: yes. Define the exposure window from the earliest documented breach through correction of all failures, and add a buffer to cover earlier undocumented breaches (e.g., a full reprocessing cycle before the first logged event). Include every patient who underwent ERCP with either scope in that window. Notify patients in writing with clinician follow-up, notify the local public health authority, and consult it about whether to offer screening (rectal culture for CRE, and clinical evaluation for anyone symptomatic). Also notify the manufacturer and file a MedWatch report if a device defect is identified. Send the three patient isolates for typing to determine whether they match.
2. What immediate corrective actions would you require before either scope returns to service, and how would you evaluate the FDA-recommended move to sterilization?
Read the worked answer
Take both scopes out of service now. Quarantine them, repeat cleaning and high-level disinfection or terminal sterilization, and do not use them again until the process failures are corrected.
Correct the system, not just the people:
- Retrain every reprocessing technician with documented competency and direct observation of the full manual cleaning sequence, including the elevator brush.
- Fix after-hours workflow: dedicated trained reprocessing staff on all shifts, or a written, IFU-compliant hold-and-transport procedure with a maximum time to cleaning and a signed log.
- Set par levels for brushes as a critical supply, switch to single-use brushes, and define an escalation path when supplies run out (stop the procedure, not the cleaning step).
- Verify AER performance (chemical and biological indicators per IFU, OPA minimum effective concentration testing), and confirm the storage cabinet maintains the required drying and hanging configuration.
Sterilization evaluation: FDA has recommended that facilities transition duodenoscopes to terminal sterilization (ethylene oxide) or a liquid chemical sterilant processing system, and to newer device designs. Do not simply switch: ETO requires aeration time, so you need additional scope inventory or a validated cycle plan, plus a contract and air-quality review. Sterilization also does not eliminate the need for meticulous manual cleaning - it adds a lethal terminal step after cleaning fails. Bring the endoscopy medical director, central processing, and administration into a written transition plan with dates.
3. Design a scope surveillance culture program. What would you sample, how often, and how would you interpret a positive result?
Read the worked answer
Method: sample after completion of full reprocessing, using a flush-brush-flush technique with neutralizing broth through the working channel and, critically, the elevator mechanism, where contamination concentrates. Plate and quantify organisms rather than reporting a binary growth/no-growth.
Frequency: risk-based, driven by your breach history and volume. A defensible starting point is monthly cultures per scope until each scope has at least three consecutive negatives with process controls verified, then quarterly. Any process breach (delayed cleaning, missed brush, AER fault, positive culture) resets that scope to monthly.
Interpretation - this is where programs go wrong:
- High-concern organisms at any quantity (Enterobacterales, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus spp., Candida spp.) = a reprocessing failure. Remove the scope from service, repeat cleaning and disinfection or sterilize, investigate the process, and consider patient notification for exposures since the last negative culture.
- Low-concern organisms (coagulase-negative staphylococci, Bacillus, diphtheroids) in low colony counts may reflect sampling or handling contamination; they are not automatically a breach but must be trended and investigated if they recur on the same scope.
- A single positive result is a signal, not a verdict - look at the process logs for that day before concluding.
Leading indicators matter more than cultures: cleaning start-time adherence, brush availability, AER indicator logs, storage cabinet humidity and hanging configuration, and competency records. Report both to the endoscopy quality committee monthly.